annual accounts payable:
$14.59M+$7.14M(+95.77%)Summary
- As of today (July 27, 2025), NTLA annual accounts payable is $14.59 million, with the most recent change of +$7.14 million (+95.77%) on December 31, 2024.
- During the last 3 years, NTLA annual accounts payable has risen by +$4.94 million (+51.13%).
- NTLA annual accounts payable is now at all-time high.
Performance
NTLA Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$12.36M-$2.23M(-15.25%)Summary
- As of today (July 27, 2025), NTLA quarterly accounts payable is $12.36 million, with the most recent change of -$2.23 million (-15.25%) on March 31, 2025.
- Over the past year, NTLA quarterly accounts payable has dropped by -$1.32 million (-9.68%).
- NTLA quarterly accounts payable is now -34.29% below its all-time high of $18.82 million, reached on June 30, 2024.
Performance
NTLA quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
NTLA Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +95.8% | -9.7% |
| 3 y3 years | +51.1% | +22.0% |
| 5 y5 years | +270.2% | +219.5% |
NTLA Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +183.1% | -34.3% | +248.0% |
| 5 y | 5-year | at high | +270.2% | -34.3% | >+9999.0% |
| alltime | all time | at high | +7231.2% | -34.3% | >+9999.0% |
NTLA Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $12.36M(-15.3%) |
| Dec 2024 | $14.59M(+95.8%) | $14.59M(+11.0%) |
| Sep 2024 | - | $13.14M(-30.1%) |
| Jun 2024 | - | $18.82M(+37.5%) |
| Mar 2024 | - | $13.69M(+83.7%) |
| Dec 2023 | $7.45M(+44.6%) | $7.45M(+109.7%) |
| Sep 2023 | - | $3.55M(-69.5%) |
| Jun 2023 | - | $11.63M(+68.9%) |
| Mar 2023 | - | $6.89M(+33.7%) |
| Dec 2022 | $5.15M(-46.6%) | $5.15M(+17.6%) |
| Sep 2022 | - | $4.38M(-41.7%) |
| Jun 2022 | - | $7.51M(-25.9%) |
| Mar 2022 | - | $10.14M(+5.0%) |
| Dec 2021 | $9.65M(-7.7%) | $9.65M(+29.2%) |
| Sep 2021 | - | $7.47M(+9.0%) |
| Jun 2021 | - | $6.85M(-21.1%) |
| Mar 2021 | - | $8.69M(-16.9%) |
| Dec 2020 | $10.46M | $10.46M(+34.5%) |
| Sep 2020 | - | $7.78M(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $7000.00(-99.8%) |
| Mar 2020 | - | $3.87M(-1.8%) |
| Dec 2019 | $3.94M(+45.5%) | $3.94M(-13.3%) |
| Sep 2019 | - | $4.55M(+146.1%) |
| Jun 2019 | - | $1.85M(-49.9%) |
| Mar 2019 | - | $3.69M(+36.2%) |
| Dec 2018 | $2.71M(+24.7%) | $2.71M(+54.4%) |
| Sep 2018 | - | $1.75M(+423.6%) |
| Jun 2018 | - | $335.00K(-82.5%) |
| Mar 2018 | - | $1.92M(-11.8%) |
| Dec 2017 | $2.17M(-53.3%) | $2.17M(-1.0%) |
| Sep 2017 | - | $2.19M(-3.2%) |
| Jun 2017 | - | $2.27M(+58.1%) |
| Mar 2017 | - | $1.43M(-69.2%) |
| Dec 2016 | $4.65M(+242.1%) | $4.65M(+608.1%) |
| Sep 2016 | - | $657.00K(-36.9%) |
| Jun 2016 | - | $1.04M(-13.6%) |
| Mar 2016 | - | $1.21M(-11.3%) |
| Dec 2015 | $1.36M(+583.4%) | $1.36M |
| Dec 2014 | $199.00K | - |
FAQ
- What is Intellia Therapeutics, Inc. annual accounts payable?
- What is the all time high annual accounts payable for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. annual accounts payable year-on-year change?
- What is Intellia Therapeutics, Inc. quarterly accounts payable?
- What is the all time high quarterly accounts payable for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. quarterly accounts payable year-on-year change?
What is Intellia Therapeutics, Inc. annual accounts payable?
The current annual accounts payable of NTLA is $14.59M
What is the all time high annual accounts payable for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high annual accounts payable is $14.59M
What is Intellia Therapeutics, Inc. annual accounts payable year-on-year change?
Over the past year, NTLA annual accounts payable has changed by +$7.14M (+95.77%)
What is Intellia Therapeutics, Inc. quarterly accounts payable?
The current quarterly accounts payable of NTLA is $12.36M
What is the all time high quarterly accounts payable for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high quarterly accounts payable is $18.82M
What is Intellia Therapeutics, Inc. quarterly accounts payable year-on-year change?
Over the past year, NTLA quarterly accounts payable has changed by -$1.32M (-9.68%)